The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FIREFLY-1: A phase 2 study of the pan-RAF inhibitor DAY101 in pediatric patients with low-grade glioma.
 
Lindsay Baker Kilburn
Employment - Kaiser Permanente (I)
Consulting or Advisory Role - Roche/Genentech
Research Funding - Epizyme (Inst); Novartis (Inst); Regeneron (Inst)
 
Nada Jabado
No Relationships to Disclose
 
Andrea Franson
No Relationships to Disclose
 
Susan N. Chi
No Relationships to Disclose
 
Michael J. Fisher
Honoraria - AstraZeneca
Research Funding - Array BioPharma; AstraZeneca; Exelixis
Travel, Accommodations, Expenses - AstraZeneca; SpringWorks Therapeutics
 
Darren R. Hargrave
Honoraria - Bayer
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Janssen; Lilly; Novartis; PureTech; Roche/Genentech; SomaNautix
Research Funding - AstraZeneca
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Novartis; Roche/Genentech
Other Relationship - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Epizyme; Janssen; Novartis
 
Jordan R. Hansford
Consulting or Advisory Role - Bayer
 
David S. Ziegler
Consulting or Advisory Role - Amgen; Bayer
Travel, Accommodations, Expenses - Bayer
 
Daniel Landi
No Relationships to Disclose
 
Hyoung Jin Kang
No Relationships to Disclose
 
Nicolas U. Gerber
No Relationships to Disclose
 
Michal Yalon-Oren
No Relationships to Disclose
 
Izzy Cornelio
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Samuel C. Blackman
Employment - Day One Biopharmaceuticals
Leadership - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Michael Craig Cox
Employment - Day One Biopharmaceuticals; Loxo; Puma Biotechnology
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Olaf Witt
Consulting or Advisory Role - AstraZeneca; Bayer; BMS; Day One Therapeutics; Janssen Research & Development; Novartis; Roche
Research Funding - BioMed Valley Discoveries (Inst)
 
Michael Prados
Stock and Other Ownership Interests - Quadriga Biosciences; xCures
Consulting or Advisory Role - Nativis
Research Funding - Bristol-Myers Squibb (Inst); Day One Therapeutics (Inst); Genentech/Roche (Inst); Novartis (Inst); Oncoceutics (Inst); Regeneron (Inst)
Expert Testimony - Nativis; Oncoceutics
Travel, Accommodations, Expenses - Nativis; Oncoceutics
 
Sabine Mueller
No Relationships to Disclose